Inspire Medical Systems Stock (NYSE:INSP)
Previous Close
$172.93
52W Range
$123.00 - $257.40
50D Avg
$202.56
200D Avg
$187.42
Market Cap
$5.18B
Avg Vol (3M)
$590.65K
Beta
1.36
Div Yield
-
INSP Company Profile
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
INSP Performance
Peer Comparison
Ticker | Company |
---|---|
TMDX | TransMedics Group, Inc. |
INMD | InMode Ltd. |
PODD | Insulet Corporation |
CLPT | ClearPoint Neuro, Inc. |
PEN | Penumbra, Inc. |
DXCM | DexCom, Inc. |
GKOS | Glaukos Corporation |
GMED | Globus Medical, Inc. |
NVCR | NovoCure Limited |
NARI | Inari Medical, Inc. |
TNDM | Tandem Diabetes Care, Inc. |
SWAV | ShockWave Medical, Inc. |
OM | Outset Medical, Inc. |